EnvisionRxOptions, a wholly owned subsidiary of Rite Aid and parent of EnvisionRx announced that Ben Bulkley, an established executive with more than 20 years’ experience in healthcare and technology, has joined the pharmacy benefits and services company as chief executive officer. He fills the role left vacant when former CEO Frank Sheehy retired last fall. Bill Epling, current president of EnvisionRxOptions will continue in that role, reporting to Ben.
Ben was most recently chief executive officer and co-founder of Trellis Rx, a private equity-backed company that builds specialty pharmacies for health systems. Prior to Trellis Rx, he led the specialty businesses of Aetna, including its pharmacy, behavioral health, and TPA businesses. His pharmacy responsibilities included benefit design, clinical, compliance, pharmaceutical contracting, network management, employer sales, mail order and specialty pharmacies.
He has also served as chief operating officer of Allscripts, a healthcare IT platform provider focused on connected care; senior vice president of global commercial operations at Invitrogen, a provider of life sciences technologies for disease research and drug discovery; and vice president and general manager of global services in the IT division of General Electric’s Healthcare business. He earned a master’s degree in Public Health from Dartmouth Geisel School of Medicine in 2018; a bachelor’s degree in Electrical Engineering from the University of Connecticut and a master’s degree in Systems Engineering from Gannon University.
“Ben is an entrepreneurial leader with extensive healthcare and technology experience along with a proven track record of driving results through innovation and operational excellence,” said John Standley, chief executive officer of Rite Aid. “We will benefit tremendously from his knowledge and expertise as he leads the EnvisionRxOptions team and advances our efforts to provide an even higher level of care and service to our customers, patients and clients.”
“Ben’s entrepreneurial mindset fits well with the heritage and growth-focused culture of the company. His extensive healthcare and technology experience will be very valuable in helping us further improve our operations, so we can take advantage of our growing scale to offer stronger pricing, while continuing to offer the flexibility and customization our clients prefer,” said Bill Epling, president of EnvisionRxOptions. “We look forward to the positive impact his leadership will bring.”